Dan Leonard
Stock Analyst at UBS
(1.97)
# 1038
Out of 5,328 analysts
281
Total ratings
52.41%
Success rate
9.76%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
GH Guardant Health | Maintains: Strong Buy | 65 70 | 49.67 | 40.93% | 9 | May 1, 2025 | |
RVTY Revvity | Upgrades: Buy | 145 115 | 94.45 | 21.76% | 2 | May 1, 2025 | |
TMO Thermo Fisher Scient... | Maintains: Buy | 715 500 | 427.26 | 17.02% | 15 | Apr 24, 2025 | |
DHR Danaher | Maintains: Buy | 275 240 | 199.25 | 20.45% | 14 | Apr 23, 2025 | |
TXG 10x Genomics | Maintains: Neutral | 20 14 | 8.28 | 69.08% | 4 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 260 255 | 154.55 | 65% | 13 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 25 | 13.05 | 91.57% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 250 185 | 119.63 | 54.64% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 102 66 | 40.19 | 64.22% | 10 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 9 | 5.7 | 57.89% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 420 350 | 310.38 | 12.76% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 16 16 | 13.54 | 18.17% | 9 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 420 385 | 243.44 | 58.15% | 19 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 80 | 50.7 | 57.79% | 10 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 17.48 | 100.23% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 160 150 | 107.77 | 39.19% | 20 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 200 | 77.86 | 156.87% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 11 | 2.02 | 444.55% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 70 | 152.99 | -54.25% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 75 90 | 46.98 | 91.57% | 9 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 7 | 7.41 | -5.53% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 160 | n/a | n/a | 12 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 345 | 346.33 | -0.38% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 260 | 147.07 | 76.79% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 1 | n/a | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 160 145 | 178.31 | -18.68% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 90 | 57.8 | 55.71% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 62 64 | 42.51 | 49.73% | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 330 340 | 241.92 | 40.54% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 24 | 20.94 | 14.61% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 1350 1500 | 1072.87 | 39.81% | 8 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 4 2 | n/a | n/a | 3 | May 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 45 35 | 7.21 | 385.44% | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 80 55 | n/a | n/a | 3 | May 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Hold | 18 0 | n/a | n/a | 3 | May 7, 2018 |